Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy

被引:31
|
作者
Zhu, Huang [1 ]
Lai, Yi-Shin [1 ]
Li, Ye [1 ]
Blum, Robert H. [1 ]
Kaufman, Dan S. [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92103 USA
关键词
Cancer immunotherapy; Adoptive cell therapy; Human pluripotent stem cell; T cell; Natural Killer cell; Natural Killer T cell; NATURAL-KILLER-CELLS; CHIMERIC ANTIGEN RECEPTORS; UMBILICAL-CORD BLOOD; TUMOR-INFILTRATING LYMPHOCYTES; ACUTE MYELOID-LEUKEMIA; T-CELLS; HEMATOPOIETIC STEM; NK CELLS; IN-VIVO; ADOPTIVE TRANSFER;
D O I
10.1002/stem.2754
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Human pluripotent stem cells (PSCs) provide a promising resource to produce immune cells for adoptive cellular immunotherapy to better treat and potentially cure otherwise lethal cancers. Cytotoxic T cells and natural killer (NK) cells can now be routinely produced from human PSCs. These PSC-derived lymphocytes have phenotype and function similar to primary lymphocytes isolated from peripheral blood. PSC-derived T and NK cells have advantages compared with primary immune cells, as they can be precisely engineered to introduce improved anti-tumor activity and produced in essentially unlimited numbers.
引用
收藏
页码:134 / 145
页数:12
相关论文
共 50 条
  • [1] Natural killer cell-based immunotherapy for cancer
    Ma, Shoubao
    Yu, Jianhua
    Caligiuri, Michael A.
    JOURNAL OF IMMUNOLOGY, 2025,
  • [2] NK cell-based immunotherapy for cancer
    Fang, Fang
    Xiao, Weihua
    Tian, Zhigang
    SEMINARS IN IMMUNOLOGY, 2017, 31 : 37 - 54
  • [3] Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications
    Lei, Qi
    Deng, Hongkui
    Sun, Shicheng
    LIFE MEDICINE, 2025, 4 (01):
  • [4] Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy
    Sachamitrt, Patty
    Hackett, Simon
    Fairchild, Paul Jonathan
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [5] Concise Review: Immunologic Lessons From Solid Organ Transplantation for Stem Cell-Based Therapies
    Loewendorf, Andrea
    Csete, Marie
    STEM CELLS TRANSLATIONAL MEDICINE, 2013, 2 (02) : 136 - 142
  • [6] Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials
    Suen, Wade Chun-Wai
    Lee, Wayne Yuk-Wai
    Leung, Kam-Tong
    Pan, Xiao-Hua
    Li, Gang
    CANCER INVESTIGATION, 2018, 36 (08) : 431 - 457
  • [7] NK Cell-Based Immunotherapy in Colorectal Cancer
    Della Chiesa, Mariella
    Setti, Chiara
    Giordano, Chiara
    Obino, Valentina
    Greppi, Marco
    Pesce, Silvia
    Marcenaro, Emanuela
    Rutigliani, Mariangela
    Provinciali, Nicoletta
    Paleari, Laura
    DeCensi, Andrea
    Sivori, Simona
    Carlomagno, Simona
    VACCINES, 2022, 10 (07)
  • [8] New frontiers in cell-based immunotherapy of cancer
    D'Elios, Mario Milco
    Del Prete, Gianfranco
    Amedei, Amedeo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (05) : 623 - 641
  • [9] The rise of human stem cell-derived natural killer cells for cancer immunotherapy
    Wang, Kejian
    Han, Yue
    Cho, William C.
    Zhu, Huang
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (02) : 141 - 148
  • [10] Current progress in NK cell biology and NK cell-based cancer immunotherapy
    Tarazona, Raquel
    Lopez-Sejas, Nelson
    Guerrero, Beatriz
    Hassouneh, Fakhri
    Valhondo, Isabel
    Pera, Alejandra
    Sanchez-Correa, Beatriz
    Pastor, Nieves
    Duran, Esther
    Alonso, Corona
    Solana, Rafael
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (05) : 879 - 899